LGA
BSX icon

Lebenthal Global Advisors’s Boston Scientific BSX Stock Holding History

Lebenthal Global Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-800
Closed -$50.2K – 207
2026
Q1 		$50.2K Buy
800
+600
+300% +$48K 0.01% 190
2025
Q4 		$19.1K Buy
+200
New +$19.6K ﹤0.01% 183

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lebenthal Global Advisors's BSX Position: Q2 2026 in Review

Lebenthal Global Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 21,807 shares — an estimated $1.37M sold.

Lebenthal Global Advisors first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $2.02M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lebenthal Global Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Lebenthal Global Advisors sold 21,807 Boston Scientific shares in Q2 2026, an estimated $1.37M.
  • Lebenthal Global Advisors first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • Lebenthal Global Advisors's Boston Scientific position peaked at $2.02M in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lebenthal Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.